MyAverix Finance
F · Healthcare
FORTRESS BIOTECH.PRF.A 25 (CNB0)
Biotechnology
FORTRESS BIOTECH.PRF.A 25 (CNB0) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported P/E ratio is 18.00, net margin is 6.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CNB0
FORTRESS BIOTECH.PRF.A 25 (CNB0) — FAQ
What is CNB0's P/E ratio?
The price-to-earnings (P/E) ratio for FORTRESS BIOTECH.PRF.A 25 (CNB0) is 18.00 (data as of 2026-03-28).
Does FORTRESS BIOTECH.PRF.A 25 pay a dividend?
Dividend yield is not available in the current snapshot for FORTRESS BIOTECH.PRF.A 25 (CNB0). Check the MyAverix Finance app for the latest dividend data.
What sector is FORTRESS BIOTECH.PRF.A 25 in?
FORTRESS BIOTECH.PRF.A 25 (CNB0) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CNB0 listed on?
CNB0 is listed on F.
What is FORTRESS BIOTECH.PRF.A 25's net margin?
FORTRESS BIOTECH.PRF.A 25 (CNB0) reports a net margin of 6.4% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.